Skip to main content

Peer Review reports

From: Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review

Original Submission
2 Feb 2023 Submitted Original manuscript
8 Mar 2023 Reviewed Reviewer Report
7 May 2023 Reviewed Reviewer Report
19 May 2023 Author responded Author comments - Vandenbussche Nicolas
8 Jun 2023 Reviewed Reviewer Report
9 Jun 2023 Reviewed Reviewer Report
Resubmission - Version 2
19 May 2023 Submitted Manuscript version 2
Publishing
10 Jun 2023 Editorially accepted
22 Jun 2023 Article published 10.1186/s10194-023-01611-3

You can find further information about peer review here.

Back to article page